This paper examines the explanatory power of a uni-factor asset pricing model (CAPM) against a multi-factor model (The Fama-French three factor model) in explaining excess portfolio returns on non-financial firms on the Ghana Stock Exchange (GSE). Data covering the period January 2002 to December 2011 were used. A six Size-Book-to-Market (BTM) ratio portfolios were formed and used for the analysis. The paper revealed that, a uni-factor model like the (CAPM) could not predict satisfactorily, the excess portfolio returns on the Ghana Stock Exchange. By using the multi-factor asset pricing model, that is, the Fama-French Three Factor Model, excess portfolio returns were better explained. It is then conclusive enough that, the multi-factor asset pricing model introduced by Fama and French (1992) was a better asset pricing model to explain excess portfolio returns on the Ghana Stock Exchange than the Capital Assets Pricing Model (CAPM) and that there exist the firm size and BTM effects on the Ghanaian Stock market.
This paper investigates the applicability of the Fama-French Three Factor Model in explaining, portfolio returns on the Ghana Stock Exchange. Following the model and variables proposed originally by Fama and French (1992), two additional variables firm size and Book-to-Market (BTM) ratio are added in a six Size-BTM portfolios to the excess returns on the market portfolio. Data from the Ghana Stock Exchange database covering the period between 2002 and 2011 were used for the analysis. The results reveal that the portfolio returns on the Ghana stock exchange are better explained by the three factor model proposed by Fama and French (1992).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.